Anterior Chamber Intraocular Lens, Pseudophakic Bullous Keratopathy
Conditions
Keywords
Descemet membrane endothelial keratoplasty DMEK, Anterior chamber intraocular lens AC IOL, pseudophakic bullous keratopathy PBK
Brief summary
Surgical treatment of corneal endothelial decompensation in the presence of an anterior chamber intraocular lens (AC IOL) is technically challenging. The ultimate management is to perform Descemet membrane endothelial keratoplasty (DMEK). However , unfolding the DMEK graft in the presence of an AC IOL can be difficult and injurious to the graft so the investigators recommend exchanging the AC IOL with a posterior chamber IOL first. In this study , the investigators aim to compare the outcome and complications of performing DMEK and IOL exchange as combined one stage surgery versus .sequential 2 stage procedure
Detailed description
Pseudophakic Bullous keratopathy is the second leading indication for endothelial keratoplasty. One of the main controversies in the management of PBK in the presence of an AC IOl is whether to retain the IOL or perform an IOL exchange with a PC IOL. The investigators believe that retention of an AC IOL can be hazardous to the DMEK graft due to reduced depth of the anterior chamber and traumatic touch between the graft and the IOL during graft unfolding and even postoperatively. On the other hand , performing an IOL exchange is relatively time consuming and requires excess manipulation of the iris tissue with the risk of intraoperative hyphema and postoperative inflammation which can affect the endothelial graft survival and cell count. Aim of the study : to compare the outcome and complications between performing intraocular lens (IOL) exchange and Descemet membrane endothelial keratoplasty (DMEK) as single stage versus two stage procedure in the management of pseudophakic bullous keratopathy associated with anterior chamber IOL. Methods : The study will be a prospective randomized controlled trial. Eligible subjects with pseudophakic bullous keratopathy and AC IOL will be assigned into two groups each comprising 10 eyes. One group will undergo AC IOL exchange with posterior chamber (PC) IOL ( Poly methyl methacrylate (PMMA) lens or iris claw lens if there is no adequate capsular support) combined with DMEK in the same setting. The other group will undergo 2 stage procedure ; first one is IOL exchange , iridoplasty (if required) and inferior peripheral iridectomy and the second stage is DMEK one month later.
Interventions
PROCEDUREDescemet membrane endothelial keratoplasty DMEK
DMEK : it involves separating the Descemet membrane from a corneal donor graft , doing a descematorhexis in the recepient cornea , loading and injection of the graft into the anterior chamber , unfolding and fixing the graft to the recepient cornea by intracameral air bubble.
PROCEDUREIOL exchange
IOL exchange : it involves performing a corneoscleral tunnel , freeing the AC IOL from any adhesions and explanting it through the tunnel , then implanting a posterior chamber PMMA lens or iris claw lens if there is no adequate capsular support.
PROCEDUREiridoplasty
iridoplasty : repairing any iris defect by using 10/0 prolene.
PROCEDUREInferior peripheral iridectomy
Inferior peripheral iridectomy : performed by vannus scissor to avoid postoperative pupillary block due to the intracameral air .
Sponsors
Alexandria University
Study design
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
randomized controlled trial
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patients having pseudophakic bullous keratopathy associated with an anterior chamber intraocular lens. 2. Age above 18 years old.
Exclusion criteria
1. Patients with corneal stromal scarring . 2. Patients who had prior glaucoma drainage devices implantation. 3 Patient with non-repairable loss in the iris tissue.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative AC inflammatory reactions | 1 month postoperatively | postoperative AC inflammatory reactions including cell and flare will be determined by slit lamp examination under high magnification: AC cells will be graded according to the Standardization of Uveitis Nomenclature (SUN) group grading system as following : Grade 0 : 5 or less cells in 1\*1mm slit beam Grade 1 : 6- 15 cells in 1\*1mm slit beam Grade II : 16-25 cells in 1\*1mm slit beam Grade III : 26-50 cells in 1\*1mm slit beam grade IV : more than 50 cells in 1\*1mm slit beam . AC flare will be graded according to the SUN grading system : Grade 0 : none Grade I : faint Grade II : moderate ( iris and lens details still seen ) Grade III : Marked ( iris and lens details hazy) Grade IV : intense ( fixed and plastic aqueous ). |
| postoperative endothelial cell loss in percentage | 3 months | The postoperative endothelial cell count will be determined in cell/mm2 using the Konan Cellchek specular microscope (Konan Medical , Irvine, California , USA) at 3 months and compared to the preoperative endothelial cell count of the donor graft to calculate the percentage of endothelial cell loss |
| Best spectacle corrected visual acuity | 3 months | best spectacle corrected visual acuity using the decimal system |
| postoperative hyphema and and intraocular pressure spikes | 1month postoperatively | Any postoperative hyphema and anterior chamber inflammatory reactions will determined by slit lamp examination: Hyphema if found will be graded into : 1. Microscopic hyphema : circulating red blood cells in the AC 2. Grade I : less than one third the AC 3. Grade II: one third to one half the AC 4. Grade III: more than one half the AC but not total 5. Grade IV : total hyphema. and intraocular pressure spikes will detected using the Goldmann applanation tonometer to measure the intraocular pressure in mmHg |
| Postoperative intraocular pressure spikes | 1 month postoperatively | postoperative intracular pressure will be measured by Goldmann Applanation Tonometer in mmHg |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Keratometric values | 3 months | Keratometric values will be determined in Diopters using Autorefractometer/Keratometer , the difference between the steep and flat keratometric values will determine the corneal astigamtism in diopters |
| central corneal thickness | 3 months postoperatively | central corneal thickness will be determined in micrometer using the Konan Cellchek specular microscope (Konan Medical , Irvine, California , USA) |
| Spherical equivalent | 3 months postoperatively | spherical equivalent will be determined using the autorefractometer in diopters |
| graft detachment | 1 week postoperatively | The occurrence of postoperative graft detachment will be determined by slit lamp examination . The incidence of graft detachment will be determined in each group . |
Countries
Egypt
Contacts
Primary ContactMohamed M Kolaib, MBBCh
Backup ContactMohamed B Goweida, MD
Outcome results
None listed